Some 60-70% of men with advanced metastatic prostate cancer will experience bone pain as their disease progresses. Bones are one of the major targets for prostate cancer metastasis and along with these mets will come pain. There is never any reason not to have your bone pain controlled. Your quality of life should rule your [...]
As we progress through the various twists and turns of our treatment it is not uncommon to decide that you want to switch your doctors. It is also an excellent idea to occasionally seek a second opinion to insure that you are in fact getting cutting edge treatment. Once you have decided to change a [...]
Earlier this month Novacea, Inc. (NASDAQ: NOVC) announced that it has prematurely ended its Phase 3 ASCENT-2 clinical trial of Asentar, also known as DN-101. Asentar had been the company's lead investigational cancer therapy for the treatment of those of us who are androgen-independent (AIP). The Data Safety Monitoring Board (DSMB) for the clinical study [...]
Dr. Pathak and associates from Kaiser Permanente, Los Angeles published an article in the June 2007 issue of the Journal of Urology, basing the frequency of LHRH agonist serum on testosterone levels instead of a fixed cookie cutter schedule currently used by most physicans. Patients usually receive a depot injection of an LHRH agonist based [...]
Today’s front page of the New York Times had a feature article about the quality of drugs and chemicals that have continued to flow out of China into the pharmaceutical industry. There are no regulations and no inspections of these chemical plants which means that many of the products being produced and sold throughout the [...]